Daniel E. Salazar
Vice President of Clinical & Regulatory at Brace Pharma
About
Salazar leads clinical and regulatory work at Brace Pharma Capital and is Chief Scientific Officer and board member at EMS S/A. He has over 25 years in drug discovery and development, contributing to 40+ IND filings and 9 NDAs, and is an adjunct associate professor at the University of Florida. He previously held a senior translational medicine role at Otsuka Pharmaceutical Development.